Legal & General Group PLC Standard Biotools Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 287,544 shares of LAB stock, worth $454,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
287,544
Previous 287,544
-0.0%
Holding current value
$454,319
Previous $554,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding LAB
# of Institutions
144Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$113 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$92.7 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$34.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$27.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$24.1 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $124M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...